Lenzing's €600m Transformation Bet Carries a Human Toll That Markets Are Still Pricing In
Published on 09/08/2026 at 13:23 | Editorial boerse-global.de
For a company whose shares have drifted roughly 24 percent below their 52-week peak, the question hovering over Lenzing is no longer whether the Austrian fibre maker can turn itself around — but what the final bill for that turnaround will look like. The answer, it turns out, involves both a freshly approved capital injection and the elimination of around 2,000 jobs across two continents.
Shareholders gave the green light at an extraordinary general meeting roughly a fortnight ago to a capital increase of approximately €300 million, which must be executed by 25 February 2027 at the latest. Combined with a planned €300 million in debt financing, the package hands Lenzing a €600 million war chest to underwrite its "Grow Nonwovens, Reset Textiles" strategy — a pivot that means expanding in nonwovens while deliberately shrinking the traditional textile fibre business.
The Cost of Reinvention
That strategic retreat comes with hard landings in specific communities. Production at Heiligenkreuz in Austria's Burgenland region is slated to wind down by the end of 2026, with the site earmarked for sale. Across the Channel, the Grimsby facility in England is scheduled to follow suit by 2027. Taken together, the closures will cost roughly 2,000 positions worldwide — the flip side of the "broad approval" CEO Georg Kasperkovitz said the plan received from investors, including anchor shareholders B&C-Gruppe, Suzano and Oberbank.
The financial drag of the transition is equally tangible. Lenzing expects impairment charges on long-term assets of up to €150 million this year, plus restructuring provisions of up to €40 million that will weigh on EBITDA. A parallel cost-saving programme targets €120 million in savings by the end of 2027 relative to the 2025 baseline, following a board decision in late July to consolidate fibre production sites and accelerate the transformation.
Should investors sell immediately? Or is it worth buying Lenzing?
Fresh Faces, Fresh Capital
The governance overhaul accompanying the restructuring is notable for its speed. Kasperkovitz, who stepped up from chief operating officer to the top job on 1 June for a term running to the end of May 2029, retains his COO responsibilities alongside the CEO role. He took over after predecessor Rohit Aggarwal resigned in December citing personal reasons. The supervisory board, meanwhile, has welcomed Martin Seiter as a new member, elected at the same extraordinary meeting that approved the capital raise.
A Profit Story the Market Has Yet to Embrace
The restructuring is not born of desperation, at least judging by the half-year figures published just over three weeks ago. Net profit after tax more than doubled to €35.6 million from €15.2 million in the prior-year period. EBITDA reached €239.2 million on revenue of €1.27 billion, while free cash flow edged up to €45.8 million from €43.1 million.
Investors, however, have responded with a shrug. The stock has shed 2.2 percent since the results were released and sits roughly 5.7 percent below its 200-day moving average of €24.14. On a 30-day view, the shares are down around 3.8 percent, trading at €22.70 against a prior close of €22.75 — a level that leaves the stock about 24 percent shy of its €29.75 52-week high.
The market's ambivalence is understandable. Lenzing is simultaneously a turnaround candidate and a work in progress, with short-term restructuring costs competing against the promise of a leaner cost base and a fortified balance sheet. For the 2,000 employees whose positions are already earmarked for elimination, the arithmetic is brutally simple. For shareholders, the equation hinges on whether the €600 million financing package — and the operational recovery now taking shape — proves sufficient to build a durable new Lenzing. The coming quarterly results, rather than any single shareholder vote, will supply the first meaningful verdict.
Ad
Lenzing Stock: New Analysis - 8 September
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
